Skip to main content Deutsch

Therapeutic Hypothermia - Targeted Temperature Control (TTC)

Therapeutic Hypothermia - Targeted Temperature Control (TTC)

Mild therapeutic hypothermia has been used in recent years as an effective therapy to reduce mortality and neurological sequelae in resuscitated patients.

Successfully resuscitated patients are cooled to a core body temperature of 32-34°C for a period of 24 hours, and the treatment itself is performed under anesthesia and controlled ventilation. Once cooling is complete, anesthesia is terminated and slow awakening is allowed.

New cooling methods and the optimization of further treatment under therapeutic hypothermia are investigated at our department, as is the extension of the use of therapeutic hypothermia to other diseases such as stroke or acute myocardial infarction.